查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1855905

2025年全球In Silico蛋白質設計市場報告

In Silico Protein Design Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，In Silico蛋白質設計市場呈指數級成長，預計從2024年的15.4億美元成長到2025年的18.7億美元，複合年成長率高達21.4%。這段歷史性成長時期的主要促進因素包括：人們對蛋白質療法的認知不斷提高、對先進免疫療法的興趣日益濃厚、對永續和環境友好型生物技術解決方案的需求不斷成長、人們越來越重視透過蛋白質設計來提高藥物療效，以及雲端基礎技術在研究中的日益普及。

預計未來幾年，In Silico輔助蛋白質設計市場將呈指數級成長，到2029年市場規模將達到40.2億美元，複合年成長率（CAGR）為21.1%。預測期內的成長預計將受到以下因素的推動：機器學習在蛋白質建模領域的應用日益廣泛、計算生物學投資不斷增加、對經濟高效的藥物發現方法的需求不斷成長、對精準醫療的日益重視以及生物製藥需求的不斷上升。預測期內的關鍵趨勢包括：人工智慧主導的蛋白質建模技術的進步、量子運算的整合、自動化蛋白質設計平台的開發、從頭蛋白質合成技術的創新以及多組體學資料整合技術的進步。

In Silico輔助蛋白質設計是指利用電腦建模和模擬技術，而非實驗室實驗，來創建或修改蛋白質結構的過程。計算工具用於預測胺基酸序列的折疊和相互作用方式，從而設計出具有特定形狀和功能的蛋白質。這種方法能夠加速蛋白質發現，降低成本，並使研究人員能夠在實驗檢驗之前探索多種可能性。

用於In Silico蛋白質設計的軟體主要分為雲端基礎軟體和本地部署軟體。雲端基礎軟體是指運行在網際網路上的數位平台，用戶無需在本機上安裝或維護即可存取高級蛋白質設計應用程式。這些工具融合了分子建模、人工智慧、機器學習演算法和同源建模等技術。應用領域包括藥物發現與開發、酵素工程、生物標記發現、疫苗學和學術研究。最終用戶包括製藥和生物技術公司以及學術研究機構。

美國在2025年春季突然提高關稅及其引發的貿易摩擦對製藥公司造成了嚴重衝擊。利潤豐厚的學名藥生產商尤其脆弱，一些公司不得不縮減低利潤藥物的生產規模。生物技術公司也因關稅導致的專用試劑短缺而面臨臨床試驗延期。為因應這一局面，製藥業正在印度和歐洲擴大原料藥的生產，增加庫存，並遊說政府對基本藥物給予貿易豁免。

本In Silico報告是商業研究公司（The Business Research Company）最新系列報告的一部分，該系列報告提供電腦輔助蛋白質設計市場統計數據，例如全球電腦輔助蛋白質設計行業的市場規模、區域佔有率、市場In Silico排名、詳細In Silico市場細分、市場趨勢和商業機會，以及在In Silico蛋白質設計行業取得成功所需的數據。這份In Silico輔助In Silico設計市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析，為您提供所需的一切觀點。

未來幾年，對個人化醫療日益成長的需求預計將推動In Silico蛋白質設計市場的發展。個人化醫療是指根據個人的基因譜、生活方式和環境因素來制定個人化的治療和預防策略。基因組技術的進步以及以價值為導向的醫療模式的日益普及，推動了這項需求的成長。這些模式旨在改善患者預後並降低整體醫療成本。In Silico蛋白質設計能夠快速創建針對特定患者需求的治療性蛋白質，從而為個人化醫療提供支援。例如，個人化醫療聯盟（PMC）在2024年2月報告稱，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病患者的新型個人化療法。這種對個人化醫療需求的激增正在推動In Silico蛋白質設計市場的成長。

In Silico蛋白質設計市場中的公司正在開發先進的解決方案，例如一鍵式蛋白質設計平台，以加速藥物發現、提高治療效果並促進新型生技藥品的研發。一鍵式蛋白質設計平台是一種自動化工具，使研究人員能夠以最少的人工干預快速設計和修飾蛋白質。例如，總部位於英國的生物技術公司 Latent Labs 於 2025 年 7 月推出了 Latent-X，這是一種生成式人工智慧模型，使用戶無需編程專業知識即可上傳標靶並在原子水平上設計大環化合物和微型結合劑。該平台對大環化合物和粘合劑的命中率很高，實現了皮莫耳到微莫耳級的結合親和性，並具有實驗室檢驗的特異性。該系統產生完整蛋白質序列和結構的速度也遠超傳統方法，標誌著蛋白質治療領域的重大飛躍，並加速了該領域的創新。

2023年7月，德國生技公司BioNTech SE收購了InstaDeep Ltd.，以增強其人工智慧能力。此次收購將BioNTech在免疫療法和疫苗研發方面的專長與InstaDeep先進的人工智慧和機器學習技術相結合，從而強化人工智慧驅動的藥物發現和開發。夥伴關係旨在促進創新治療方法的研發，尤其是在癌症和感染疾病領域。總部位於英國的InstaDeep Ltd.In Silico蛋白質設計技術而聞名，此次收購可望加速前沿治療藥物的研發。

In Silico輔助蛋白質設計市場由提供蛋白質結構建模、蛋白質工程與最佳化、抗體和生物設計、分子對接以及虛擬篩檢等服務的營業單位所獲得的收入所構成。市場價值包括服務供應商銷售的或包含在其服務產品中的相關產品的價值。該市場還包括最佳化蛋白質、酵素變體、胜肽、候選疫苗、蛋白質模型和研究試劑套件的銷售。該市場的價值為“出廠價”，即產品製造商或創建者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品價值。該市場的產品價值還包括產品創建者提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球In Silico蛋白質設計：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 終端用戶產業分析
  • 全球In Silico蛋白質設計市場：成長率分析
  • 全球In Silico蛋白質設計市場表現：規模與成長，2019-2024年
  • 全球In Silico蛋白質設計市場預測：規模與成長，2024-2029年，2034年預測
  • 全球In Silico蛋白質設計：潛在市場規模 (TAM)

第6章 市場細分

  • 全球In Silico蛋白質設計市場：依軟體類型、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 雲端基礎的軟體
  • 本地部署軟體
  • 全球In Silico蛋白質設計市場：依技術類型、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 分子建模
  • 人工智慧和機器學習演算法
  • 同源建模
  • 其他技術類型
  • 全球In Silico蛋白質設計市場：按應用、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 藥物發現與開發
  • 酵素工程
  • 生物標記發現
  • 疫苗學
  • 學術研究
  • 全球In Silico蛋白質設計市場：依最終使用者、效能和預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 製藥和生物技術公司
  • 學術研究機構
  • 其他最終用戶
  • 全球In Silico蛋白質設計市場：雲端基礎軟體、類型、實際值及預測值細分，2019-2024年、2024-2029年預測值、2034年預測值
  • 訂閱制
  • 按次付費
  • 混合雲端
  • 全球In Silico蛋白質設計市場：依本地部署軟體、類型、效能和預測細分，2019-2024年、2024-2029年預測、2034年預測
  • 企業許可證
  • 永久許可
  • 客製化解決方案

第7章 區域和國家分析

  • 全球In Silico蛋白質設計市場：依地區、績效及預測分類，2019-2024年、2024-2029年預測、2034年預測
  • 全球In Silico蛋白質設計市場：按國家、績效和預測，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • In Silico蛋白質設計市場：競爭格局
  • In Silico輔助蛋白質設計市場：公司簡介
    • Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
    • Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Generate Biomedicines Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Chemical Computing Group ULC Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Arzeda Corp.
  • Outpace Bio Inc.
  • Evozyne Inc.
  • Cradle Bio BV
  • Seismic Therapeutics Inc.
  • Profluent Bio Inc.
  • Nabla Bio Inc.
  • Antiverse Ltd.
  • EvolutionaryScale Inc.
  • RevolKa Ltd.
  • Molecular Discovery Ltd.
  • Inte：Ligand GmbH
  • Kuano Ltd.
  • AI Proteins Inc.
  • Menten AI Inc.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

  • 2029年In Silico蛋白質設計市場：提供新機會的國家
  • 2029年In Silico蛋白質設計市場：新興細分市場機會
  • 2029年In Silico蛋白質設計市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章附錄

簡介目錄
Product Code: r38554

In silico protein design is the process of creating or modifying protein structures using computer-based modeling and simulations rather than laboratory experiments. It employs computational tools to predict how amino acid sequences will fold and interact, enabling the design of proteins with specific shapes and functions. This approach accelerates discovery, reduces costs, and allows researchers to explore numerous possibilities before experimental validation.

The primary software types for in silico protein design include cloud-based software and on-premise software. Cloud-based software refers to digital platforms that operate over the internet, providing access to advanced protein design applications without requiring installation or maintenance on local computers. These tools incorporate technologies such as molecular modeling, artificial intelligence and machine learning algorithms, homology modeling, and others. Applications include drug discovery and development, enzyme engineering, biomarker discovery, vaccinology, and academic research. End users include pharmaceutical and biotechnology companies, academic and research institutions, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The in silico protein design market research report is one of a series of new reports from The Business Research Company that provides in silico protein design market statistics, including in silico protein design industry global market size, regional shares, competitors with a in silico protein design market share, detailed in silico protein design market segments, market trends and opportunities, and any further data you may need to thrive in the in silico protein design industry. This in silico protein design market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in silico protein design market size has grown exponentially in recent years. It will grow from $1.54 billion in 2024 to $1.87 billion in 2025 at a compound annual growth rate (CAGR) of 21.4%. Growth in the historic period was driven by rising awareness of protein therapeutics, growing interest in advanced immunotherapies, increasing demand for sustainable and eco-friendly biotechnology solutions, stronger focus on enhancing drug efficacy through protein design, and greater use of cloud-based technologies in research.

The in silico protein design market size is expected to see exponential growth in the next few years. It will grow to $4.02 billion in 2029 at a compound annual growth rate (CAGR) of 21.1%. Growth in the forecast period is expected to result from expanding applications of machine learning in protein modeling, increased investment in computational biology, greater demand for cost-effective drug discovery approaches, rising emphasis on precision medicine, and growing demand for biopharmaceuticals. Key trends anticipated for the forecast period include advancements in AI-driven protein modeling, integration of quantum computing, development of automated protein design platforms, innovation in de novo protein synthesis, and progress in multi-omics data integration.

The growing demand for personalized medicine is expected to drive the growth of the in silico protein design market in the coming years. Personalized medicine tailors medical treatments and prevention strategies to an individual's genetic profile, lifestyle, and environmental factors. This demand is increasing due to advancements in genomic technologies and the growing adoption of value-based care models, which focus on improving patient outcomes while reducing overall healthcare costs. In silico protein design supports personalized medicine by enabling the rapid creation of customized therapeutic proteins that are tailored to specific patient needs. For example, in February 2024, the Personalized Medicine Coalition (PMC) reported that the FDA approved 16 new personalized treatments for rare disease patients in 2023, a significant rise from six approvals in 2022. This surge in demand for personalized medicine is fueling the growth of the in silico protein design market.

Companies in the in silico protein design market are developing advanced solutions, such as push-button protein design platforms, to speed up drug discovery, enhance therapeutic efficacy, and facilitate the creation of novel biologics. Push-button protein design platforms are automated tools that allow researchers to quickly design and modify proteins with minimal manual intervention. For instance, in July 2025, UK-based biotechnology company Latent Labs launched Latent-X, a generative AI model that enables users with no coding expertise to upload targets and design macrocycles and mini-binders at the atomic level. This platform delivers high hit rates for macrocycles and mini-binders and achieves picomolar to micromolar binding affinities with lab-verified specificity. The system also produces complete protein sequences and structures much faster than previous methods, making it a significant leap forward in protein therapeutics and accelerating innovation in the field.

In July 2023, BioNTech SE, a German biotechnology company, acquired InstaDeep Ltd. to strengthen its AI capabilities. This acquisition combines BioNTech's expertise in immunotherapy and vaccine development with InstaDeep's advanced artificial intelligence and machine learning technologies, enhancing AI-powered drug discovery and development. The partnership aims to improve the creation of innovative therapies, particularly in cancer and infectious diseases. InstaDeep Ltd., a UK-based company, is known for its in silico protein design technologies, and this acquisition is expected to accelerate the development of cutting-edge therapeutics.

Major players in the in silico protein design market are Dassault Systemes SE, Schrodinger Inc., Generate Biomedicines Inc., Insilico Medicine Inc., Chemical Computing Group ULC, Arzeda Corp., Outpace Bio Inc., Evozyne Inc., Cradle Bio B.V., Seismic Therapeutics Inc., Profluent Bio Inc., Nabla Bio Inc., Antiverse Ltd., EvolutionaryScale Inc., RevolKa Ltd., Molecular Discovery Ltd., Inte:Ligand GmbH, Kuano Ltd., AI Proteins Inc., and Menten AI Inc.

North America was the largest region in the in silico protein design market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in in silico protein design report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the in silico protein design market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The in silico protein design market consists of revenues earned by entities by providing services such as protein structure modelling, protein engineering and optimization, antibody and biologic design, molecular docking, and virtual screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The in silico protein design market also includes sales of optimized proteins, enzyme variants, peptides and vaccine candidates, protein models, and research kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In Silico Protein Design Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on in silico protein design market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in silico protein design ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in silico protein design market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Software Type: Cloud-Based Software; On-Premise Software
  • 2) By Technology Type: Molecular Modelling; Artificial Intelligence And Machine Learning Algorithms; Homology Modelling; Other Technology Types
  • 3) By Application: Drug Discovery And Development; Enzyme Engineering; Biomarker Discovery; Vaccinology; Academic Research
  • 4) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Cloud-Based Software: Subscription-Based; Pay-Per-Use; Hybrid Cloud
  • 2) By On-Premise Software: Enterprise License; Perpetual License; Customized Solutions
  • Companies Mentioned: Dassault Systemes SE; Schrodinger Inc.; Generate Biomedicines Inc.; Insilico Medicine Inc.; Chemical Computing Group ULC; Arzeda Corp.; Outpace Bio Inc.; Evozyne Inc.; Cradle Bio B.V.; Seismic Therapeutics Inc.; Profluent Bio Inc.; Nabla Bio Inc.; Antiverse Ltd.; EvolutionaryScale Inc.; RevolKa Ltd.; Molecular Discovery Ltd.; Inte:Ligand GmbH; Kuano Ltd.; AI Proteins Inc.; Menten AI Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. In Silico Protein Design Market Characteristics

3. In Silico Protein Design Market Trends And Strategies

4. In Silico Protein Design Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global In Silico Protein Design Growth Analysis And Strategic Analysis Framework

  • 5.1. Global In Silico Protein Design PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global In Silico Protein Design Market Growth Rate Analysis
  • 5.4. Global In Silico Protein Design Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global In Silico Protein Design Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global In Silico Protein Design Total Addressable Market (TAM)

6. In Silico Protein Design Market Segmentation

  • 6.1. Global In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cloud-Based Software
  • On-Premise Software
  • 6.2. Global In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Molecular Modelling
  • Artificial Intelligence And Machine Learning Algorithms
  • Homology Modelling
  • Other Technology Types
  • 6.3. Global In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery And Development
  • Enzyme Engineering
  • Biomarker Discovery
  • Vaccinology
  • Academic Research
  • 6.4. Global In Silico Protein Design Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmaceutical And Biotechnology Companies
  • Academic And Research Institutes
  • Other End-Users
  • 6.5. Global In Silico Protein Design Market, Sub-Segmentation Of Cloud-Based Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Subscription-Based
  • Pay-Per-Use
  • Hybrid Cloud
  • 6.6. Global In Silico Protein Design Market, Sub-Segmentation Of On-Premise Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enterprise License
  • Perpetual License
  • Customized Solutions

7. In Silico Protein Design Market Regional And Country Analysis

  • 7.1. Global In Silico Protein Design Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global In Silico Protein Design Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific In Silico Protein Design Market

  • 8.1. Asia-Pacific In Silico Protein Design Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China In Silico Protein Design Market

  • 9.1. China In Silico Protein Design Market Overview
  • 9.2. China In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India In Silico Protein Design Market

  • 10.1. India In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan In Silico Protein Design Market

  • 11.1. Japan In Silico Protein Design Market Overview
  • 11.2. Japan In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia In Silico Protein Design Market

  • 12.1. Australia In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia In Silico Protein Design Market

  • 13.1. Indonesia In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea In Silico Protein Design Market

  • 14.1. South Korea In Silico Protein Design Market Overview
  • 14.2. South Korea In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe In Silico Protein Design Market

  • 15.1. Western Europe In Silico Protein Design Market Overview
  • 15.2. Western Europe In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK In Silico Protein Design Market

  • 16.1. UK In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany In Silico Protein Design Market

  • 17.1. Germany In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France In Silico Protein Design Market

  • 18.1. France In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy In Silico Protein Design Market

  • 19.1. Italy In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain In Silico Protein Design Market

  • 20.1. Spain In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe In Silico Protein Design Market

  • 21.1. Eastern Europe In Silico Protein Design Market Overview
  • 21.2. Eastern Europe In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia In Silico Protein Design Market

  • 22.1. Russia In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America In Silico Protein Design Market

  • 23.1. North America In Silico Protein Design Market Overview
  • 23.2. North America In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA In Silico Protein Design Market

  • 24.1. USA In Silico Protein Design Market Overview
  • 24.2. USA In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada In Silico Protein Design Market

  • 25.1. Canada In Silico Protein Design Market Overview
  • 25.2. Canada In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America In Silico Protein Design Market

  • 26.1. South America In Silico Protein Design Market Overview
  • 26.2. South America In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil In Silico Protein Design Market

  • 27.1. Brazil In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East In Silico Protein Design Market

  • 28.1. Middle East In Silico Protein Design Market Overview
  • 28.2. Middle East In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa In Silico Protein Design Market

  • 29.1. Africa In Silico Protein Design Market Overview
  • 29.2. Africa In Silico Protein Design Market, Segmentation By Software Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa In Silico Protein Design Market, Segmentation By Technology Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa In Silico Protein Design Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. In Silico Protein Design Market Competitive Landscape And Company Profiles

  • 30.1. In Silico Protein Design Market Competitive Landscape
  • 30.2. In Silico Protein Design Market Company Profiles
    • 30.2.1. Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Generate Biomedicines Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Insilico Medicine Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Chemical Computing Group ULC Overview, Products and Services, Strategy and Financial Analysis

31. In Silico Protein Design Market Other Major And Innovative Companies

  • 31.1. Arzeda Corp.
  • 31.2. Outpace Bio Inc.
  • 31.3. Evozyne Inc.
  • 31.4. Cradle Bio B.V.
  • 31.5. Seismic Therapeutics Inc.
  • 31.6. Profluent Bio Inc.
  • 31.7. Nabla Bio Inc.
  • 31.8. Antiverse Ltd.
  • 31.9. EvolutionaryScale Inc.
  • 31.10. RevolKa Ltd.
  • 31.11. Molecular Discovery Ltd.
  • 31.12. Inte:Ligand GmbH
  • 31.13. Kuano Ltd.
  • 31.14. AI Proteins Inc.
  • 31.15. Menten AI Inc.

32. Global In Silico Protein Design Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The In Silico Protein Design Market

34. Recent Developments In The In Silico Protein Design Market

35. In Silico Protein Design Market High Potential Countries, Segments and Strategies

  • 35.1 In Silico Protein Design Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 In Silico Protein Design Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 In Silico Protein Design Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer